Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy.

@article{Berkovic2013SalvageSB,
  title={Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy.},
  author={Patrick Berkovic and Gert De Meerleer and Louke J. Delrue and Bieke Lambert and Val{\'e}rie Fonteyne and Nicolaas Lumen and Karel Decaestecker and Geert Villeirs and Philippe Vuye and Piet Ost},
  journal={Clinical genitourinary cancer},
  year={2013},
  volume={11 1},
  pages={27-32}
}
BACKGROUND We investigated whether repeated stereotactic body radiotherapy (SBRT) of oligometastatic disease is able to defer the initiation of palliative androgen deprivation therapy (ADT) in patients with low-volume bone and lymph node metastases. PATIENTS AND METHODS Patients with up to 3 synchronous metastases (bone and/or lymph nodes) diagnosed on positron emission tomography, following biochemical recurrence after local curative treatment, were treated with (repeated) SBRT to a dose of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 8 times over the past 90 days. VIEW TWEETS